Synthia™ software is a computer-aided approach that efficiently searches possible pathways for target molecules to accelerate drug discovery.
This webinar presents an overview of Synthia™ including details on how it was developed and validated. The customised search functions, such as target selection, type of analysis, rules and filters, scoring functions and stop conditions, as well as result filters will be demonstrated in a live demo and an informative Q&A session will follow.
The sophisticated algorithms and expert database, comprised of more than 74,000 expert-coded rules, expedites finding viable pathways for synthetic targets.
PhD Technical Application Scientist
Gardener is responsible for the commercial licensing of Synthia™, the revolutionary retrosynthetic design software. She received her PhD in organic chemistry from Brown University under Professor Jason Sello where she worked on developing new methodology for synthesising antibacterial peptide natural products. Prior to joining Merck in 2018, Gardener was a senior scientist at Vitae Industries, a pharmaceutical technologies start-up in Providence RI.
Chemistry and synthesis
Research. Development. Production.
We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.